HHMI
PRQR icon

Howard Hughes Medical Institute’s ProQR Therapeutics PRQR Stock Holding History

Howard Hughes Medical Institute’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-695
Closed -$3K – 182
2016
Q1 		$3K Sell
695
-70
-9% -$356 ﹤0.01% 158
2015
Q4 		$7K Sell
765
-42
-5% -$483 ﹤0.01% 163
2015
Q3 		$12K Buy
807
+211
+35% +$3.53K ﹤0.01% 156
2015
Q2 		$10K Buy
+596
New +$11.2K ﹤0.01% 159

Other funds holding PRQR

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Howard Hughes Medical Institute's PRQR Position: Q2 2016 in Review

Howard Hughes Medical Institute sold out of ProQR Therapeutics (PRQR) in Q2 2016, closing a stake of 695 shares — an estimated $3K sold.

Howard Hughes Medical Institute first reported a position in PRQR in Q2 2015 and held it in 4 quarters. The position peaked at $12K in Q3 2015. 26 funds tracked by Wall St. Rank hold PRQR as of Q2 2016.

  • Howard Hughes Medical Institute reported no remaining ProQR Therapeutics position as of Q2 2016 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 695 ProQR Therapeutics shares in Q2 2016, an estimated $3K.
  • Howard Hughes Medical Institute first reported a position in ProQR Therapeutics in Q2 2015 and held it in 4 quarters.
  • Howard Hughes Medical Institute's ProQR Therapeutics position peaked at $12K in Q3 2015.
  • 26 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q2 2016.

Based on Howard Hughes Medical Institute's 13F filing for Q2 2016, filed 3 Aug 2016.